Strong Women Study
Impact of Encapsulated Fruit, Berry and Vegetable Juice Powder Concentrate on Oxidative Stress, Inflammation and Blood Flow Before and Post Exercise in Overweight, Middle-aged, Women.
1 other identifier
interventional
44
1 country
1
Brief Summary
The investigators investigate the impact of an encapsulated fruit, berry and vegetable juice powder concentrate on oxidative stress, inflammation and blood flow before and post exercise in overweight, middle-aged, women. Main hypotheses (H1):
- The nutraceutical has an impact on oxidative stress reduction.
- The nutraceutical has an impact on inflammation.
- The nutraceutical has an impact on blood flow and microcirculation.
- Walking exercise for 30 minutes has an impact on oxidative stress- and inflammation markers.
- Walking exercise for 30 minutes has an impact on blood flow and microcirculation
- The combination of nutraceutical supplementation + walking exercise for 30 minutes has an impact on oxidative stress- and inflammation markers, and on blood flow/microcirculation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 16, 2011
CompletedFirst Posted
Study publicly available on registry
November 22, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedApril 10, 2013
April 1, 2013
6 months
November 16, 2011
April 9, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Carbonyl groups on protein, oxidized LDL, Malondialdehyde, TNF-alpha, IL-6, Trombelastometry and peripheral microcirculation
Carbonyl groups on protein as indicators of protein oxidation; oxidized LDL, Malondialdehyde as indicators of Lipidoxidation; TNF-alpha, IL-6 as indicators of inflammation; Trombelastometry: clotting time, thrombocyte ahesion, trombocyte aggregation from whole blood as indicators for blood flow and hemostasis; Peripheral microcirculation in subcutis as indicator for blood flow in peripheral subcutis.
6 months
Study Arms (2)
fruit, berry and vegetable concentrate
ACTIVE COMPARATOR20 ladies receive an encapsulated, powdered fruit, berry and vegetable concentrate for 8 weeks
20 women with placebo
PLACEBO COMPARATORplacebo for 8 weeks
Interventions
6 capsules of supplement or placebo for 8wk
Eligibility Criteria
You may qualify if:
- women
- BMI \> 27
- praemenopausal
- non smokers
- eligibility for exercise
- wk wash out
You may not qualify if:
- male
- all people not matching this age group
- BMI \> 40 and \< 27
- peri- or postmenopausal women
- smokers
- all women taking dietary supplements
- all women that fail in ergometric exercise eligibility testing, refering to the standards in sports medicine (e.g.: significant ST-decrease or increase, blood pressure \> 240 mmHg, tachycardia, polymorphic extrasystolia, cyanosis, bradyarrhythmia..)
- Diabetics
- osteoporosis or osteopenia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Green Beatlead
Study Sites (1)
Medical University of Graz
Graz, 8010, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manfred Lamprecht, PhD PhD
Medical University of Graz
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
November 16, 2011
First Posted
November 22, 2011
Study Start
October 1, 2011
Primary Completion
April 1, 2012
Study Completion
December 1, 2012
Last Updated
April 10, 2013
Record last verified: 2013-04